glp-1 drugs compounded Compounded" | Health Communication Research Laboratory Facts About Compounded GLP-1 Drugs
Description
Hi, I'm Katie Bailey
GLP-1 receptor agonists (GLP-1 RAs), already established in the management of type 2 diabetes mellitus and obesity, have emerged as promising candidates for the treatment of nonalcoholic steatohepatitis (NASH), owing to their broad metabolic and hepatoprotective effects
In one study in healthy humans, i.v
In addition, 37.0% of people treated with 2.4 mg semaglutide achieved improvements in liver fibrosis with no worsening of steatohepatitis compared to 22.5% on placebo
